Free Trial

Electromed (ELMD) Competitors

Electromed logo
$19.16 -0.53 (-2.69%)
Closing price 04:00 PM Eastern
Extended Trading
$19.19 +0.03 (+0.16%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELMD vs. BBNX, AXGN, BVS, SMLR, ZIMV, AVNS, KIDS, CBLL, TMCI, and DCTH

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Beta Bionics (BBNX), AxoGen (AXGN), Bioventus (BVS), Semler Scientific (SMLR), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), OrthoPediatrics (KIDS), CeriBell (CBLL), Treace Medical Concepts (TMCI), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

Electromed vs. Its Competitors

Beta Bionics (NASDAQ:BBNX) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

40.8% of Electromed shares are held by institutional investors. 14.0% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to Beta Bionics' net margin of 0.00%. Electromed's return on equity of 15.71% beat Beta Bionics' return on equity.

Company Net Margins Return on Equity Return on Assets
Beta BionicsN/A N/A N/A
Electromed 11.34%15.71%13.37%

Beta Bionics currently has a consensus target price of $22.56, indicating a potential upside of 42.04%. Electromed has a consensus target price of $33.50, indicating a potential upside of 74.84%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than Beta Bionics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beta Bionics
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.75
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00

Electromed has lower revenue, but higher earnings than Beta Bionics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beta Bionics$65.12M10.60-$54.76MN/AN/A
Electromed$61.44M2.62$5.15M$0.7924.25

In the previous week, Beta Bionics had 4 more articles in the media than Electromed. MarketBeat recorded 4 mentions for Beta Bionics and 0 mentions for Electromed. Beta Bionics' average media sentiment score of 0.70 beat Electromed's score of 0.00 indicating that Beta Bionics is being referred to more favorably in the media.

Company Overall Sentiment
Beta Bionics Positive
Electromed Neutral

Summary

Electromed beats Beta Bionics on 9 of the 14 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$160.68M$33.96M$5.73B$20.95B
Dividend YieldN/AN/A4.54%3.59%
P/E Ratio25.552.8730.7428.29
Price / Sales2.62208.70441.0554.39
Price / Cash41.3641.3637.3423.83
Price / Book3.762.148.885.22
Net Income$5.15M-$2.66M$3.26B$992.74M
7 Day Performance-0.93%2.48%1.73%0.29%
1 Month Performance5.10%9.17%3.54%1.13%
1 Year Performance28.59%154.46%28.63%11.00%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
1.2197 of 5 stars
$19.16
-2.7%
$33.50
+74.8%
+30.0%$160.68M$61.44M25.55160
BBNX
Beta Bionics
2.7911 of 5 stars
$14.30
-3.0%
$22.56
+57.7%
N/A$640.75M$65.12M0.00294News Coverage
Positive News
AXGN
AxoGen
3.0457 of 5 stars
$14.01
+0.8%
$26.00
+85.6%
+32.1%$639.58M$187.34M-140.09450Short Interest ↑
BVS
Bioventus
3.0529 of 5 stars
$6.93
+0.1%
$13.75
+98.4%
-17.3%$569.26M$564.14M-11.361,200
SMLR
Semler Scientific
3.1673 of 5 stars
$35.28
-2.4%
$81.75
+131.7%
+15.5%$534.89M$56.29M4.30120Gap Up
ZIMV
ZimVie
0.4397 of 5 stars
$18.83
+0.1%
$17.75
-5.7%
+6.1%$530.46M$449.75M-26.901,770Short Interest ↑
AVNS
AVANOS MEDICAL
3.069 of 5 stars
$10.52
-2.8%
N/A-51.8%$502.08M$687.80M8.872,227Short Interest ↑
KIDS
OrthoPediatrics
3.9752 of 5 stars
$18.81
-0.5%
$34.14
+81.5%
-29.8%$474.14M$204.73M0.00200
CBLL
CeriBell
2.5633 of 5 stars
$12.12
-6.1%
$32.14
+165.2%
N/A$473.33M$65.44M-4.05N/A
TMCI
Treace Medical Concepts
2.6209 of 5 stars
$6.39
+4.2%
$9.83
+53.9%
+13.9%$387.25M$209.36M0.00250
DCTH
Delcath Systems
2.4701 of 5 stars
$10.51
+5.0%
$24.50
+133.1%
+42.0%$350.16M$37.21M83.4260Short Interest ↑

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 8/19/2025 by MarketBeat.com Staff
From Our Partners